Bristol-Myers Squibb | Lucro Operacional



Operating Profit Alterar Data
AbbVie USD 5.72B 1.98B 2025-06
Abbott USD 2.07B 415M 2025-06
ALKERMES USD 92.98M 79.19M 2025-06
Amgen USD 1.29B 1.02B 2025-03
AstraZeneca USD 3.51B 166M 2025-06
Biogen USD 851.8M 540.6M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Drreddys Laboratories INR 18.72B 1.17B 2024-12
Eli Lilly USD 7.02B 1.61B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
J&J USD 6.94B 6.69B 2025-06
Medtronic USD 1.44B 210M 2025-04
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Novo Nordisk 34.08B 4.71B 2025-06
Perrigo USD 55.6M 23.8M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Prestige Brands USD 71.76M 16.67M 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
Sanofi EUR 861M 2.77B 2024-12
United Therapeutics USD 276.9M 105.9M 2025-06
Zoetis USD 1.02B 205M 2025-06


Bristol-Myers Squibb Lucro Operacional - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.